The economic burden of HIV-associated wasting in the era of modern antiretroviral therapy.
Siddiqui J, Samuel SK, Hayward B, Wirka KA, Deering KL, Harshaw Q, Phillips A, Harbour M.
Siddiqui J, et al. Among authors: phillips a.
J Manag Care Spec Pharm. 2022 Oct;28(10):1180-1189. doi: 10.18553/jmcp.2022.22097. Epub 2022 Aug 8.
J Manag Care Spec Pharm. 2022.
PMID: 35939048
Total all-cause costs were calculated as the sum of payments for hospitalizations, emergency department visits, outpatient visits, and pharmacy use. A multivariate generalized linear model with log-link and gamma distribution was used to estimate the impact of HIVAW predic …
Total all-cause costs were calculated as the sum of payments for hospitalizations, emergency department visits, outpatient visits, and pharm …